SCHEMBL19398134

SCHEMBL19398134

CCn1cc(C(=O)Nc2ccc(-c3cc(C4CCN(C(=O)N(C)C)CC4)n4ncnc(N)c34)cc2)c(=O)n(-c2cccc(F)c2)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 11/20 1.00
▸ TYRO3 Q06418 11/20 0.83
▸ AXL P30530 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19398131 0.93 MERTK (0.88) MERTKTYRO3AXL
SCHEMBL19398137 0.93 MERTK (1.00) MERTKTYRO3AXL
SCHEMBL19429607 0.92 MERTK (0.85) MERTKTYRO3AXL
SCHEMBL19398133 0.91 TYRO3 (1.00) MERTKTYRO3AXL
SCHEMBL19398141 0.85 TYRO3 (1.00) MERTKTYRO3AXL
SCHEMBL19429498 0.85 TYRO3 (1.00) MERTKTYRO3AXL
SCHEMBL21925066 0.85 TYRO3 (0.84) MERTKTYRO3AXL
SCHEMBL19398135 0.84 MERTK (1.00) MERTKTYRO3AXL
SCHEMBL19398127 0.84 TYRO3 (1.00) MERTKTYRO3
SCHEMBL19398121 0.84 TYRO3 (1.00) MERTKTYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147430-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2021-05-20 — — US disclosed
US-10844069-B2 Pyrrolotriazine compounds as TAM inhibitors INCYTE CORPORATION (US) 2020-11-24 — — US disclosed
US-20200131185-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2020-04-30 — — US disclosed
US-10442810-B2 Pyrrolotriazine compounds as TAM inhibitors INCYTE CORPORATION (US) 2019-10-15 — — US disclosed
US-9981975-B2 Pyrrolotriazine compounds as tam inhibitors INCYTE CORPORATION (US) 2018-05-29 — — US disclosed
US-9981975-B2 Pyrrolotriazine compounds as tam inhibitors INCYTE CORPORATION (US) 2018-05-29 — — US disclosed
US-20170275290-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2017-09-28 — — US disclosed
US-20170275290-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147430-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 MERTK 1/4885TYRO3 106/4885AXL 49/4885
US-10844069-B2 Pyrrolotriazine compounds as TAM inhibitors MERTK, MAP3K15, MAP3K5 MERTK 1/4885TYRO3 106/4885AXL 49/4885
US-20170275290-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 MERTK 1/4885TYRO3 106/4885AXL 49/4885
US-20200131185-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 MERTK 1/4885TYRO3 106/4885AXL 49/4885
US-10442810-B2 Pyrrolotriazine compounds as TAM inhibitors MERTK, MAP3K15, MAP3K5 MERTK 1/4885TYRO3 106/4885AXL 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback